Novel Imaging Technique to Assess Gynecologic Cancer

Status Recruiting

Clinical Trial Summary

This study will test a new type of DCE (dynamic contrast-enhanced) MRI (magnetic resonance imaging) to see whether, compared with traditional MRI, it produces better images that provide more information about tumors, which may help doctors make better decisions about treating women who have gynecologic cancer. MRI is commonly used to detect and evaluate many types of cancer, but its slow processing speed and the risk that images will be blurred if the patient moves inside the scanner can limit its use in clinical practice. DCE MRI is a new imaging technique that uses additional computer processing to collect information continuously during scanning, which produces more detailed images faster than traditional MRI, which reduces the risk of movement-related blurring and provides important information about tumor activity. The DCE MRI scan in this study will be done in a standard MRI scanner, using a contrast agent (gadobutrol; Gadavist®) that has been approved by the FDA.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Gynecologic Cancer

Clinical Trial Details

NCT number	NCT04893434
Study type	Interventional
Source	Memorial Sloan Kettering Cancer Center
Contact	Oguz Akin, MD
Phone	212-639-3458
Email	akino@mskcc.org
Status	Recruiting
Phase	Phase 1
Start date	May 13, 2021
Completion date	May 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04890327` - Web-based Family History Tool	N/A
Not yet recruiting	`NCT05467319` - Ferric Derisomaltose/Iron Isomaltoside and Outcomes in the Recovery of Gynecologic Oncology ERAS	Phase 3
Recruiting	`NCT05478876` - Carbon Ion Radiation Therapy in the Treatment of Mucous Melanomas of the Female Lower Genital Tract	N/A
Active, not recruiting	`NCT04899492` - Evaluation of Different Smoking Cessation Protocols: Nicotine Replacement, Motivational Interviewing (MI), Cognitive Behavioural Therapy (CBT) or Hypnotherapy in Cancer Patients Scheduled for Surgery	N/A
Terminated	`NCT03658109` - Lidocaine Infusion or Quadratus Lumborum Block and Intrathecal Morphine, Versus Intrathecal Morphine Alone	Early Phase 1
Recruiting	`NCT05296512` - Pembrolizumab and Lenvatinib in Clear Cell Ovarian Cancer	Phase 2
Not yet recruiting	`NCT06398314` - Palliative Radiotherapy in Symptomatic Pelvic Soft Tissue Tumors	N/A
Completed	`NCT01679483` - Efficacy Study of FloSeal for Prevention of Lymphocele After Lymphadenectomy for Gynecologic Cancer	N/A
Completed	`NCT01444924` - Transversus Abdominis Plane Blocks for Patients Undergoing Robotic Gynecologic Oncology Surgery	Phase 2
Recruiting	`NCT05053230` - A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer	N/A
Recruiting	`NCT04534075` - Dietary Fiber During Radiotherapy - a Placebo-controlled Randomized Trial	Phase 3
Active, not recruiting	`NCT04584957` - Prophylactic Negative Pressure Wound Therapy (VAC) in Gynecologic Oncology (G.O.)	N/A
Completed	`NCT03292328` - Yoga for Symptoms of Nerve Damage Caused by Chemotherapy	N/A
Completed	`NCT02459301` - A Dose-Ranging Study of IPH2201 in Patients With Gynecologic Malignancies	Phase 1
Completed	`NCT05131490` - Effect on Adaptation to Cancer of Mobile Application Developed for Gynecological Cancer Patients	N/A
Active, not recruiting	`NCT03899376` - A Trial Comparing Acute Toxicity in Patients With Gynecological Cancer Treated With VMAT	N/A
Not yet recruiting	`NCT05407987` - Ferric Derisomaltose and Outcomes in the Recovery of Gynecologic Oncology: ERAS (Enhanced Recovery After Surgery)	Phase 3
Recruiting	`NCT05891470` - To Explore the Benefits of the MonaLisa Touch® System in Gynaecological Cancer Patients Treated by (Chemo)-RT	N/A
Not yet recruiting	`NCT05974995` - Robotic-assisted Versus Conventional Laparoscopic Surgery in Obese Patients With Early Endometrial Cancer	N/A
Withdrawn	`NCT04368130` - SIGNAL:Identifying Behavioral Anomalies Using Smartphones to Improve Cancer Care	N/A